5.69
0.82 (16.84%)
| Penutupan Terdahulu | 4.87 |
| Buka | 4.91 |
| Jumlah Dagangan | 103,638 |
| Purata Dagangan (3B) | 69,930 |
| Modal Pasaran | 60,465,828 |
| Harga / Pendapatan (P/E TTM) | 35.56 |
| Harga / Jualan (P/S) | 2.95 |
| Harga / Buku (P/B) | 5.18 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | 5.16% |
| Margin Operasi (TTM) | 11.60% |
| EPS Cair (TTM) | 0.080 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 38.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 14.28% |
| Nisbah Semasa (MRQ) | 5.92 |
| Aliran Tunai Operasi (OCF TTM) | -2.03 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.57 M |
| Pulangan Atas Aset (ROA TTM) | 4.16% |
| Pulangan Atas Ekuiti (ROE TTM) | 9.17% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Nephros, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.63 |
|
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 11.19% |
| % Dimiliki oleh Institusi | 44.01% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Nov 2025 | Pengumuman | Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History |
| 30 Oct 2025 | Pengumuman | ¬Nephros Schedules Third Quarter 2025 Financial Results Conference Call |
| 08 Oct 2025 | Pengumuman | Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |